XML 37 R28.htm IDEA: XBRL DOCUMENT v3.22.2
Summary of Significant Accounting Policies (Tables)
9 Months Ended
Jun. 30, 2022
Accounting Policies [Abstract]  
Restrictions on Cash and Cash Equivalents The following table provides a reconciliation of the total cash, cash equivalents and restricted
cash reported on the Condensed Consolidated Balance Sheets to the corresponding amounts reported on the Condensed Consolidated Statements of Cash Flows.
June 30,
2022
June 30,
2021
Cash and cash equivalents$670 $545 
Restricted cash14 31 
Cash, cash equivalents and restricted cash$684 $576 
Schedule of Cash and Cash Equivalents The following table provides a reconciliation of the total cash, cash equivalents and restricted
cash reported on the Condensed Consolidated Balance Sheets to the corresponding amounts reported on the Condensed Consolidated Statements of Cash Flows.
June 30,
2022
June 30,
2021
Cash and cash equivalents$670 $545 
Restricted cash14 31 
Cash, cash equivalents and restricted cash$684 $576 
Shares Used in Computing Basic and Diluted Earnings Per Share Shares used in computing basic and diluted earnings per share are as follows: 
Three Months Ended
June 30,
Nine Months Ended
June 30,
 2022202120222021
Denominator (thousands of shares):
Weighted-average common shares outstanding — basic210,190 209,099 209,992 208,934 
Incremental shares issuable for stock options, common stock awards and Equity Units (a)— 1,752 5,973 1,260 
Weighted-average common shares outstanding — diluted210,190 210,851 215,965 210,194 
(a)For the three months ended June 30, 2022, 5,668 of such shares have been excluded as these incremental shares would be antidilutive due to the net loss for the period. At June 30, 2022 and 2021, there were 5,718 and 2,502 shares, respectively, associated with outstanding stock option awards that were not included in the computation of diluted earnings per share above because their effect was antidilutive.